How to overcome the excess ASCVD risk conferred by Lp(a)?
This video was recorded during the EAS Congress 2022 in Milan, Italy.
Alberico L. Catapano, PhD, is professor of pharmacology at the Department of Pharmacological and Biomolecular Sciences, University of Milan, Italy. He is Past President of the European Atherosclerosis Society (EAS).
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: